JCR Pharmaceuticals Co., Ltd.
4552.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$64.55B
Close$
Share Statistics
| Market cap | $64.55 Billion |
|---|---|
| Enterprise Value | $108.51 Billion |
| Dividend Yield | $20.00 (3.78%) |
| Earnings per Share | $17.86 |
| Beta | 0.42 |
| Outstanding Shares | 122,015,899 |
Return
| Return on Equity | 2.02% |
|---|---|
| Return on Assets | 0.82% |
| Return on Invested Capital | 3.23% |
Valuation & Multiples
| P/E Ratio | 78.72 |
|---|---|
| PEG | 31.88 |
| Price to Sales | 1.55 |
| Price to Book Ratio | 1.49 |
| Enterprise Value to Revenue | 2.61 |
| Enterprise Value to EBIT | 59.35 |
| Enterprise Value to Net Income | 125 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 1.25 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 30, 2026
EPS Estimate
$-11.27
Average shareholder expectationRevenue Estimate
$9.97 B
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$0.17
Average shareholder expectationRevenue Estimate
$12.62 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About JCR Pharmaceuticals Co., Ltd.
985 employees
CEO: Toru Ashida JCR Pharmaceuticals Co., Ltd. is a specialized pharmaceutical firm primarily engaged in the creation, development, manufacturing, international trade, and distribution of medicinal products, regenerative therapies, and active pharmaceuti...